Drug patent dispute to get fiercer

Published: 2008-11-17 06:55:00

Updated: 2008-11-17 06:55:00

Patent dispute for pharmaceuticals will get fiercer as many Korean drug makers are rushing to introduce first generic versions of original brands whose patents are to be expired, with hope of acquiring large share of the patented drug’s market.

According to the Korean Intellectual Property Of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK